Brain study could pave way for new stroke therapies
NCT ID NCT07423923
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the brain handles two different tasks: finding your way around and remembering daily events, like when you last took medicine. Researchers want to understand what parts of the brain are used for each task and how prior knowledge helps. The goal is to find ways to boost healthy brain function after a stroke or other brain injury. The study involves 15 healthy adults and uses brain scans and memory tests.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Early phase 1
The earliest testing in people: a first look at safety, in a very small group.
- Participants
-
About 15 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Mar 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Inclusion Criteria (for healthy young adults in fMRI studies) 1. Able to provide verbal and written informed consent 2. Fluent English speaker 3. At least 8th grade education 4. Age between 18-40 years. 5. Normal or corrected-to-normal eyesight Exclusion Criteria (for healthy young adults in fMRI studies) 1. Magnetic resonance imaging contraindications (e.g., metallic objects in body, claustrophobia) 2. Current use of anticonvulsant, neuroleptic, sedatives, or other medications known to affect cognition 3. Neurologic conditions affecting the brain (e.g., stroke, epilepsy, traumatic brain injury with loss of consciousness) 4. Psychiatric conditions (e.g., major depression, schizophrenia) Patient inclusion criteria for iEEG: Inclusion Criteria: 1\. Adult patients with medically refractory epilepsy who are scheduled to undergo or have previously undergone placement of sub-dural electrodes or depth electrodes or stereo-electroencephalography to localize the site of seizure onset. Exclusion Criteria: 1. Patients with gross structural abnormalities (hematoma, tumors, large vascular malformations, diffuse malformations of cortical development) that may impact critical perceptual or memory areas needed to perform tasks. 2. Patients who are unable to participate in memory testing due to impaired cognition or mental retardation. All patients routinely undergo a detailed neuropsychological evaluation, and the neuropsychological report will be used to make this assessment. 3. Patients/volunteers with cardiac pacemakers, intracranial aneurysm clips, or other potentially mobile implanted metallic devices cannot be included in this study, because of possible effects of high power magnetic fields on them. 4. Patients with claustrophobia who cannot undergo an MRI scan without sedation. 5. Pregnant women Patient inclusion criteria for scopolamine: 1. In good general health, aside from a history of epilepsy, as ascertained by medical history, physical examination (PE), clinical laboratory evaluations, and ECG. 2. Body mass index between 18-35 kg/m2. Patient exclusion criteria: 1. History of renal insufficiency. 2. Patients with liver failure. 3. Patients with autoimmune neuropathy. 4. Patients with uncontrolled hyperthyroidism. 5. Patients with a history of dementia. 6. Patient with a history of delirium after using transdermal scopolamine. 7. History of narrow-angle glaucoma (due to increased eye pressure). 8. History of pyloric obstruction or paralytic ileus. 9. History of myasthenia gravis, obstructive uropathy, porphyria, or myasthenia gravis. Exclusion Criteria: \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Epilepsy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Arizona Psychology Department and Evelyn McKnight Brain Institute
Tucson, Arizona, 85721, United States
-
University of Texas Southwestern Medical Center / O'Donnell Brain Institute
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can lavender and lullabies help kids with epilepsy sleep better?
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Can a Comfort-Focused education program improve life with epilepsy?
- Can video games rewire young brains after injury?
- High-Fat Diet's effect on epilepsy: scientists track brain signals
- Epilepsy drug candidate put to the test in healthy volunteers